Concepedia

Andrew Pedinoff

AP

Statistics

Publications

9

Citations

410

H-Index

9

Active since

1998

Affiliations

California Allergy and Asthma Medical Group(Current)

Bernstein Clinical Research Center

Medical Research Associates

Center for Clinical Research (United States)

Andrew Pedinoff is an author at California Allergy and Asthma Medical Group specializing in pharmacology, pharmacy, and asthma management.

Publications per year

1998–2021

9

Publications

9

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

Gary T. Ferguson, J. Mark FitzGerald, Eugene R. Bleecker et al. · The Lancet Respiratory Medicine · 2017 · 123 citations

, , +7

Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis

Anjuli Nayak, Guy A. Settipane, Andrew Pedinoff et al. · Annals of Allergy Asthma & Immunology · 2002 · 112 citations

, , +15

Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis

Frank C. Hampel, Andrew Pedinoff, Robert L. Jacobs et al. · Allergy and Asthma Proceedings · 2019 · 43 citations

, , +17

Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2)

Mario Castro, Edward Kerwin, David Miller et al. · EClinicalMedicine · 2021 · 33 citations · Full text

, , +13

Clinical aspects of allergic disease

David I. Bernstein, Robert Cohen, Elliot Ginchansky et al. · Journal of Allergy and Clinical Immunology · 1998 · 32 citations

, , +13

1–5 of 9